Enable more effective and targeted treatments that address unique needs for patients with pharmacogenomics. The traditional one-size-fits-all approach to medication has long been recognized as a ...
When data from 2220 Bupa customers in a pilot scheme were analysed, the findings appeared striking. The private health insurer reported that 99% had genetic sensitivity to certain medicines. Bupa has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results